Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of mesenchymal stem cells with biphasic calcium phosphate for jaw bone reconstruction before dental implant placement
2012-003139-50Phase 2Completed
- Sponsor
- University of Bergen
- Start
- Aug 2013
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mesenchymal stem cells and microporous biphasic calcium phosphate in Alveolar bone atrophy (ABL), sponsored by University of Bergen. Started Aug 2013; status: completed.
02
Drugs
mesenchymal stem cellsmicroporous biphasic calcium phosphate
03
Conditions
Alveolar bone atrophy (ABL)
Beyond the preview
Go deeper on 2012-003139-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003139-50.